ArticleScientific reports2015

The effectiveness of RECIST on survival in patients with NSCLC receiving chemotherapy with or without target agents as first-line treatment.

Ting Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.